冠状动脉病变钙化程度对PCI术后远期预后的影响
前瞻性观察性研究连续纳入10 119例接受PCI的冠心病患者,按造影钙化程度分为无/轻度钙化组(8 268例)和中/重度钙化组(1 851例),主要终点为术后1年MACE。中/重度钙化组1年MACE、全因死亡、心肌梗死和靶血管再次血运重建均显著高于无/轻度钙化组,中/重度钙化是1年MACE的独立预测因素(HR=1.41,95%CI 1.16~1.72,P<0.01)。
要点
- 中/重度钙化患者合并更多高危因素,介入操作时间和支架长度更长、旋磨比例更高。
- 中/重度钙化组术后1年MACE发生率为7.5%,显著高于无/轻度钙化组的4.9%。
- 中/重度钙化是PCI术后1年MACE的独立危险因素(HR=1.41,95%CI 1.16~1.72)。
核心结论
- 冠状动脉病变中/重度钙化是冠心病患者PCI术后远期预后不良的独立危险因素。
研究设计与样本
- 前瞻性观察性研究,连续纳入2013年1月1日至12月31日在我院接受PCI的冠心病患者10 119例。
- 按冠状动脉造影靶病变钙化程度分为无/轻度钙化组(8 268例)和中/重度钙化组(1 851例)。
- 主要终点为术后1年主要不良心血管事件,包括全因死亡、心肌梗死和靶血管再次血运重建。
主要发现
- 中/重度钙化组年龄(60.0±10.6)岁高于无/轻度钙化组(57.9±10.2)岁,P<0.01。
- 中/重度钙化组介入操作时间37(24,61)min、支架长度32(23,48)mm均长于无/轻度钙化组,P<0.01。
- 中/重度钙化组旋磨治疗比例2.56%(57/2 229)高于无/轻度钙化组0.03%(3/11 930),P<0.01。
关键数值与推荐
- 多因素Cox回归显示中/重度钙化是PCI术后1年MACE的独立预测因素(HR=1.41,95%CI 1.16~1.72,P<0.01)。
临床怎么用
- 对冠状动脉病变中/重度钙化患者应识别其较高危的临床特征并加强围术期和术后管理。
- 中/重度钙化患者介入操作更复杂、旋磨使用更多,需关注术后1年MACE风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the impact of coronary lesion calcification on the long-term outcome of patients with coronary heart disease after percutaneous coronary intervention. Methods: In this prospective observational study, a total of 10 119 consecutive patients with coronary heart disease undergoing percutaneous coronary intervention from January 1 to December 31, 2 103 in our hospital were enrolled. The patients were divided into non/mild calcification group (8 268 cases) and moderate/severe calcification group (1 851 cases) according to the angiographic results. The primary endpoint was one-year major adverse cardiovascular events (MACE), including all-cause death, myocardial infarction, and target vessel revascularization. Results: The patients were (58.3±10.3) years old, and there were 2 355 females (23.3%). Compared with non/mild calcification group, patients in the moderate/severe calcification group were older ((60.0±10.6) years vs. (57.9±10.2) years, P<0.01), and had higher proportion of female (25.4% (470/1 851) vs. 22.8% (1 885/8 268), P=0.02), debates (33.9% (628/1 851) vs. 29.0% (2 399/8 268), P<0.01), hypertension (68.0% (1 259/1 851) vs. 63.7% (5 264/8 268), P<0.01), coronary artery bypass grafting (4.6% (85/1 851) vs. 3.2% (268/8 268), P<0.01), stroke (12.6% (233/1 851) vs. 10.4% (861/8 268), P=0.01), and renal dysfunction (6.2% (115/1 851) vs. 3.7% (303/8 268), P<0.01). Compared with non/mild calcification group, patients in themoderate/severe calcification group experienced longer procedure time (37 (24, 61) min vs. 27 (17,40) min, P<0.01) and stent length was longer (32 (23,48) mm vs. 27 (18,38) mm, P<0.01), and percent of rotational atherectomy was higher (2.56%(57/2 229) vs. 0.03% (3/11 930), P<0.01). One-year follow-up results showed that MACE (7.5% (139/1 846) vs. 4.9% (402/8 243), P<0.01), all-cause death (1.0% (19/1 846) vs. 0.6% (49/8 243), P=0.04), myocardial infarction (2.2% (41/1 846) vs. 1.4% (114/8 243), P=0.01), and target vessel revascularization (5.0% (92/1 846) vs. 3.2% (266/8 243), P<0.01) were all significantly higher in moderate/severe calcification group than in non/mild group. Multivariate Cox regression analysis showed that moderate/severe calcification was an independent predictor of MACE at one-year after the procedure (HR=1.41, 95%CI 1.16-1.72, P<0.01). Conclusion: Moderate/severe calcification in coronary lesion is an independent predictor of long-term poor prognosis in coronary heart disease patients undergoing percutaneous coronary intervention. 目的: 探讨冠状动脉病变钙化程度对经皮冠状动脉介入治疗后冠心病患者远期预后的影响。方法: 采用前瞻性观察性研究方法,连续入选2013年1月1日至12月31日在阜外医院接受经皮冠状动脉介入治疗的冠心病患者10 119例。根据冠状动脉造影显示的靶病变钙化程度,将冠心病患者分为无/轻度钙化组(8 268例)和中/重度钙化组(1 851例)。主要研究终点为术后1年的主要不良心血管事件,包括全因死亡、心肌梗死和靶血管再次血运重建。结果: 入选患者年龄(58.3±10.3)岁,女性占23.3%(2 355例)。与无/轻度钙化组患者相比,中/重度钙化组患者年龄较大[(60.0±10.6)岁比(57.9±10.2)岁,P<0.01],女性[25.4%(470/1 851)比22.8%(1 885/8 268),P=0.02]、糖尿病[33.9%(628/1 851)比29.0%(2 399/8 268),P<0.01]、高血压[68.0%(1 259/1 851)比63.7%(5 264/8 268),P<0.01]、冠状动脉旁路移植术史[4.6%(85/1 851)比3.2%(268/8 268),P<0.01]、卒中[12.6%(233/1 851)比10.4%(861/8 268),P=0.01]和肾功能不全史[6.2%(115/1 851)比3.7%(303/8 268),P<0.01]的比例均较高。与无/轻度钙化组患者相比,中/重度钙化组患者介入治疗操作时间和置入支架长度更长[分别为37(24,61)min比27(17,40)min,P<0.01;32(23,48)mm比27(18,38)mm,P<0.01],接受旋磨治疗的比例更高[2.56%(57/2 229)比0.03%(3/11 930),P<0.01]。与无/轻度钙化组患者相比,中/重度钙化组患者术后1年发生主要不良心血管事件[7.5%(139/1 846)和4.9%(402/8 243),P<0.01]、全因死亡[1.0%(19/1 846)比0.6%(49/8 243),P=0.04]、心肌梗死[2.2%(41/1 846)比1.4%(114/8 243),P=0.01]和靶血管再次血运重建[5.0%(92/1 846)比3.2%(266/8 243),P<0.01]的比例均较高。多因素Cox回归分析显示,冠状动脉病变中/重度钙化是经皮冠状动脉介入治疗后患者发生主要不良心血管事件的独立危险因素(HR=1.41,95%CI 1.16~1.72,P<0.01)。结论: 冠状动脉病变中/重度钙化患者合并较多的高危临床因素。冠状动脉病变中/重度钙化是经皮冠状动脉介入治疗后冠心病患者远期预后不良的危险因素。.
引用
- Zhang Y, Song L, Song Y, et al. [Impact of coronary artery lesion calcification on the long-term outcome of patients with coronary heart disease after percutaneous coronary intervention]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 30669808. doi:10.3760/cma.j.issn.0253-3758.2019.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。